"Can targeting muscarinic receptors provide the answer to symptomatic treatment and disease modification in neurodegenerative disease?"

In this section
"Can targeting muscarinic receptors provide the answer to symptomatic treatment and disease modification in neurodegenerative disease?"
-

This is a past event

Prof Andrew Tobin - University of Glasgow

IMS Seminar Series - Hosted by Neuroscience